SRXH: SRx Health Solutions Inc. Forvard P/E multiplikatori

srxhealth.com (SRXH) grafik logotipi

SRx Health Solutions Inc. Kanada shifoxonalari uchun davolashni boshqarish va yuqori narxli retseptlarni yetkazib berish orqali daromad keltiradi. Kompaniyaning forward P/E ko'rsatkichi aksiyaning foydaga nisbatan baholanishini aks ettiradi va ushbu qiymat 0.00 darajasida barqarorlashgan. Maxsus infuzion markazlar biznes barqarorligini ta'minlaydi, IT monitoring bilan vertikal integratsiya esa noyob kasalliklar sektoridagi distribyutsiya risklarini samarali ravishda kamaytiradi.

SRx Health Solutions Inc. - SRXH Narxning kutilayotgan foydaga nisbati (davr: 01.05.2025 - 17.11.2026)

SRx Health Solutions (SRXH) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Fundamental baholash:SRXH SRx Health Solutions Inc
srxhealth.com brendining mahsuloti

SRx Health Solutions Inc. (SRXH) tomonidan dorixona tarmoqlari uchun AI optimallashtirishga yo'naltirilgan yuqori xarajatlar kompaniyaning kutilayotgan narx-foyda koeffitsiyentini uning texnologik salohiyatini baholash uchun asosiy filtrga aylantiradi. Ushbu ko'rsatkich joriy kotirovkani prognoz qilingan foyda bilan solishtiradi, bu esa investorlarga spekulyativ o'sishni fundamental biznesning mustahkamlanishidan ajratish va kelajakdagi foydalar uchun haddan tashqari ko'p to'lash xavfini aniqlash imkonini beradi.

SRx Health Solutions Inc. raqobatchilari tahlili

Kelajakdagi narxning foydaga nisbati Vertex Pharmaceuticals Inc. (VRTX)|Kelajakdagi narxning foydaga nisbati ALNY (Alnylam Inc.)|Forvard P/E multiplikatori INSM (insmed.com)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati United Therapeutics Corporation (UTHR)|BMRN: Prognoz qilingan narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati BBIO|BGM: Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Cogent Bio (COGT)|XERS (Xeris Biopharma Holdings) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati KROS (Keros Therapeutics, Inc.)|Prognoz qilingan narxning foydaga nisbati ARCT (Arcturus Therapeutics Holdings Inc.)|ETON (Eton Pharmaceuticals Inc) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Kamada KMDA|FULC (Fulcrum Tx) - Narxning kutilayotgan foydaga nisbati|Abeona Therapeutics Inc. - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori MREO (mereobiopharma.com)|Protalix BioTherapeutics, Inc. (PLX) - Kelajakdagi narxning foydaga nisbati|Pliant Rx (PLRX) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Applied Therapeutics, Inc.|RNTX: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Gelteq Ltd (GELS)|Prognoz qilingan narxning foydaga nisbati Aytu BioPharma AYTU|Forvard P/E multiplikatori CMMB (Chemomab Therapeutics Ltd)|Forvard P/E multiplikatori Polyrizon Ltd PLRZ|Aeterna Zentaris - Forvard P/E multiplikatori|Cyclo Therapeutics (CYTH) - Prognoz qilingan narxning foydaga nisbati|Inozyme Pharma, Inc. (INZY) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati reneopharma.com (RPHM)|Kelajakdagi narxning foydaga nisbati COSCIENS Biopharma Inc